- Measure resting heart rate: Sit quietly for 5 minutes. Count your pulse at the wrist or neck for 60 full seconds first thing in the morning, before standing or taking medications. Alternatively use a validated wearable device's resting HR average. Normal range: 60–100 bpm; values 40–60 are common in fit or older patients.
- Enter your age: The calculator uses the classic Tanaka/220-minus-age formula for estimated maximum heart rate (MHR). Both formulas have standard errors of ±10–12 bpm, so treat zones as guidelines, not hard ceilings.
- Select your CKD stage or dialysis status: This determines whether the hard zone is flagged as unsafe and adjusts the target zone recommendation in the output.
- Enter body weight in kilograms: Used only for the 30-minute calorie burn estimates. Dry weight (post-dialysis weight for HD patients) is preferred.
- Read your zones: Train so your heart rate stays within the light (40–55% HRR) or moderate (55–70% HRR) zone for most sessions. Use the Rate of Perceived Exertion (RPE) check: at the right intensity, you should be able to speak in short sentences but not sing.
- Use the calorie table: Estimates assume 30 continuous minutes at your body weight. Actual burn depends on fitness level, terrain, and interruptions.
When to Use
Use this tool to personalize exercise intensity targets for any adult with CKD, including patients on hemodialysis (HD), peritoneal dialysis (PD), or post-kidney transplant. The Karvonen formula uses both maximum heart rate and resting heart rate — accounting for individual cardiovascular fitness in a way that simple percentage-of-maximum-heart-rate formulas cannot. The calculator also estimates calorie burn for six activities commonly accessible in the Philippines using published MET (Metabolic Equivalent of Task) values.
Appropriate population
Adults with CKD Stage 3–5, maintenance hemodialysis, peritoneal dialysis, or post-kidney transplant who have received physician clearance for exercise. Most suitable for prescribing moderate-intensity aerobic training. Dialysis patients may exercise during the first 2 hours of the HD session (intradialytic exercise) or on non-dialysis days.
When to seek physician clearance first
Patients with CKD Stage 4–5 or on dialysis should obtain physician clearance before starting any new exercise program. Stop exercise immediately if you experience chest pain, severe shortness of breath, dizziness, muscle cramps, or if your heart rate exceeds the hard zone ceiling. Do not exercise on dialysis days after the session due to post-dialysis hemodynamic instability.
Pearls & Pitfalls
The RPE check is your real-time safety gauge
Heart rate monitors can lag or error at high intensities. Train your patients to use the talk test: at the right intensity (RPE 11–14 on the 6–20 Borg scale), they should be able to speak a sentence but not sing. This correlates with 55–70% HRR regardless of HR monitor accuracy.
Intradialytic exercise is safe and effective for HD patients
Exercising during the first 2 hours of the hemodialysis session leverages the cardiovascular stimulation of dialysis and actually improves dialysis adequacy (Kt/V). Post-session exercise is not recommended due to post-dialysis fatigue and hemodynamic instability. Stationary cycling on the dialysis bed is the most practical option in Philippine dialysis centers.
Resting tachycardia in dialysis patients inflates the zones
Patients on HD often have resting HRs of 90–100 bpm due to anemia, residual fluid overload, or autonomic dysfunction. A resting HR of 100 bpm makes the Karvonen light zone appear at a very high absolute HR — but the formula still correctly captures the 40–55% of available aerobic reserve. Address anemia and optimize dry weight before prescribing exercise to ensure accurate zone calculations.
Beta-blockers blunt the heart rate response
Patients on beta-blockers (carvedilol, metoprolol, bisoprolol — common in CKD for hypertension, heart failure, or arrhythmia management) will not reach their Karvonen-calculated zones at the same perceived effort. For these patients, rely primarily on RPE rather than absolute HR. The Karvonen output remains valid as an upper safety ceiling (avoid exceeding the hard zone) but should not be used as the target to hit.
Reassess zones every 2–3 months as fitness improves
As aerobic fitness improves, the resting heart rate falls — a 5–10 bpm reduction is expected after 3 months of consistent moderate training. This lowers the resting HR input, which widens the heart-rate reserve and increases the absolute BPM in each zone. Re-run the calculator quarterly and adjust the prescription accordingly.
Why Use It
Physical inactivity is one of the strongest independent predictors of mortality in CKD. Regular aerobic exercise at moderate intensity improves peak oxygen consumption (VO2 peak), reduces fatigue, lowers blood pressure, improves insulin sensitivity, and slows the rate of GFR decline in pre-dialysis CKD. Yet most CKD patients exercise well below their achievable capacity — often because they lack specific, personalized targets.
The simple formula "target HR = 220 − age × intensity%" consistently underestimates safe training intensity in individuals with a low resting heart rate (well-trained or autonomically affected) and overestimates it in those with resting tachycardia (common in advanced CKD and dialysis due to anemia, fluid overload, and autonomic neuropathy). The Karvonen method corrects for this by using the heart-rate reserve — the difference between maximum and resting HR — as the working range, anchoring intensity relative to where the patient starts rather than an age-only population average.
For dialysis patients, the maximum safe intensity is typically the light-to-moderate zone (40–70% heart-rate reserve). The hard zone (>70% HRR) is not recommended for HD and PD patients — cardiac arrhythmia risk and hemodynamic instability are substantially elevated at high intensities in end-stage renal disease, particularly on dialysis days.
Exercise Calculator — Target Heart Rate Zones & Energy Expenditure
Calculate your safe target heart rate training zones for CKD using the Karvonen formula, and estimate calorie burn for common activities by MET value. These zones are adjusted for CKD — most patients should train in the light-to-moderate zone (RPE 11–14 on the Borg scale).
⚕ Karvonen formula: Target HR = ((Max HR − Resting HR) × intensity%) + Resting HR. Max HR estimated as 220 − age (Tanaka formula gives 208 − 0.7×age; both are estimates). HRR = heart rate reserve. MET estimates per ACSM guidelines. For HD patients: exercise on non-dialysis days or during the first 2 hours of the dialysis session. Stop exercise if: chest pain, severe shortness of breath, dizziness, muscle cramps, HR exceeds hard zone. Get physician clearance before starting any exercise program in CKD Stage 4–5 or dialysis.
Next Steps
Use the result to support — not replace — clinical judgment.
- Interpret the value against the targets shown in the calculator and the Evidence section below, in the context of the full clinical picture.
- Trend serial measurements rather than acting on a single result; confirm abnormal or unexpected values before changing management.
- Apply the relevant KDIGO / specialty-guideline threshold and document the indication.
- Escalate or refer to nephrology when results are out of range, rapidly changing, or discordant with the clinical picture — and discuss the implications with the patient.
Evidence & References
Formula & Equations
| Step | Calculation | Notes |
|---|---|---|
| 1. Estimated MHR | 220 − Age | Simple formula; Tanaka alternative: 208 − (0.7 × age). Both have ±10–12 bpm SD. Use consistently. |
| 2. Heart-Rate Reserve (HRR) | MHR − Resting HR | Represents the usable aerobic working range. A higher HRR indicates better cardiovascular fitness. CKD and dialysis commonly reduce HRR due to anemia and autonomic dysfunction. |
| 3. Target HR (any intensity %) | (HRR × intensity) + Resting HR | E.g. for 55% intensity: (HRR × 0.55) + RHR. This anchors the zone to the individual's starting point rather than zero. |
| 4. Light Zone | (HRR × 0.40) + RHR to (HRR × 0.55) + RHR | RPE 10–12 (Borg 6–20 scale). Appropriate for most CKD Stage 4–5 and dialysis patients, especially those just starting exercise. |
| 5. Moderate Zone | (HRR × 0.55) + RHR to (HRR × 0.70) + RHR | RPE 13–14. Target zone for CKD Stage 3 and post-transplant patients once baseline fitness is established. |
| 6. Hard Zone | (HRR × 0.70) + RHR to (HRR × 0.85) + RHR | RPE 15–17. Not recommended for HD, PD, CKD 4–5 due to arrhythmia risk and hemodynamic instability. |
| Activity | MET value | Calorie formula (30 min) |
|---|---|---|
| Walking (brisk) | 3.5 | MET × 3.5 × body weight (kg) / 200 × 30 |
| Swimming (slow) | 5.0 | Same formula; higher MET = more calories |
| Cycling (light) | 4.0 | Stationary or flat terrain at easy pace |
| Yoga / Tai chi | 2.5 | Gentle movement; very low impact; suitable for CKD 4–5 |
| Chair exercises | 2.0 | Seated resistance and range-of-motion; safe for frail patients |
| Resistance bands | 3.0 | Light resistance training; 2× per week recommended |
Evidence & References
The Karvonen heart-rate reserve method was validated for aerobic exercise prescription in a landmark Finnish study published in 1957 and has since become the basis for personalized exercise intensity prescription in clinical cardiology and nephrology. The American College of Sports Medicine (ACSM) guidelines endorse the HRR method for intensity prescription across all clinical populations, including those with cardiovascular comorbidities. Multiple randomized controlled trials — including the EXERCISE trial and systematic reviews in the Cochrane database — demonstrate that moderate-intensity exercise 3–5 times per week improves VO2 peak, quality of life, and blood pressure in CKD Stage 3–5 and dialysis patients, with no increase in adverse events when appropriate screening is performed.
- Karvonen MJ, Kentala E, Mustala O. The effects of training on heart rate: a longitudinal study. Ann Med Exp Biol Fenn. 1957;35(3):307–315.
- American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 11th ed. Philadelphia: Wolters Kluwer; 2022.
